ESMO Opens Abstract Submissions for AI and Digital Oncology Congress 2026

<![CDATA[Five Gastrointestinal Cancer Abstracts You May Have Missed at ESMO GI 2026]]>

Tempus AI presents initial multimodal foundation model results for oncology insight generation at ASCO 2026

Model built on 2.5M patient records and 500K sequences hit 0.802 C-index and HR 4.536 in EGFR lung cancer, hinting at faster trial design an

Los científicos de los Institutos Nacionales de la Salud crearon una herramienta de inteligencia artificial para pronosticar la respuesta de los pacientes de cáncer a la inmunoterapia

Una herramienta de inteligencia artificial (IA) creada por los investigadores del Instituto Nacional del Cáncer usa datos clínicos habituale

AI Advances in Drug Discovery: From Data Integration to Dual-Action Cancer Drug Design

Featured content

AI-Driven Tumor Response Evaluation for Solid Tumors

Conditions : Solid Tumor Cancer; Neoplasms; Hepatocellular Carcinoma Interventions : Other: Observational Data Collection Sponsors : Shangha

Using AI to improve cancer immunotherapy outcomes, via training from transcriptomes of 10,000 tumor samples, 33 cancer types @NatureMedicine

Using AI to improve cancer immunotherapy outcomes, via training from transcriptomes of 10,000 tumor samples, 33 cancer types @NatureMedicine

Using AI to improve cancer immunotherapy outcomes, via training from transcriptomes of 10,000 tumor samples, 33 cancer types @NatureMedicine

Using AI to improve cancer immunotherapy outcomes, via training from transcriptomes of 10,000 tumor samples, 33 cancer types @NatureMedicine

Using AI to improve cancer immunotherapy outcomes, via training from transcriptomes of 10,000 tumor samples, 33 cancer types @NatureMedicine

Using AI to improve cancer immunotherapy outcomes, via training from transcriptomes of 10,000 tumor samples, 33 cancer types @NatureMedicine

Using AI to improve cancer immunotherapy outcomes, via training from transcriptomes of 10,000 tumor samples, 33 cancer types @NatureMedicine

Using AI to improve cancer immunotherapy outcomes, via training from transcriptomes of 10,000 tumor samples, 33 cancer types @NatureMedicine

Using AI to improve cancer immunotherapy outcomes, via training from transcriptomes of 10,000 tumor samples, 33 cancer types @NatureMedicine

Using AI to improve cancer immunotherapy outcomes, via training from transcriptomes of 10,000 tumor samples, 33 cancer types @NatureMedicine

Using AI to improve cancer immunotherapy outcomes, via training from transcriptomes of 10,000 tumor samples, 33 cancer types @NatureMedicine

Using AI to improve cancer immunotherapy outcomes, via training from transcriptomes of 10,000 tumor samples, 33 cancer types @NatureMedicine